Roche
ROG.SW
$239.50
Share price
-1.53%
Change (1 day)
-23.93%
Change (1 year)
Categories
Roche (ROG.SW) - Cash on Hand
Cash on Hand as of December 2023 : $12.50 B
According to Roche's latest financial reports the company has $12.50 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Roche - Cash on Hand chart (from 2006 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $12.50 B | 18.24% |
| 2022-12-31 | $10.57 B | -25.87% |
| 2021-12-31 | $14.26 B | 1.94% |
| 2020-12-31 | $13.99 B | 14.28% |
| 2019-12-31 | $12.24 B | -8.21% |
| 2018-12-31 | $13.33 B | 8.25% |
| 2017-12-31 | $12.32 B | 37.82% |
| 2016-12-31 | $8.93 B | -3.69% |
| 2015-12-31 | $9.28 B | -21.59% |
| 2014-12-31 | $11.83 B | -12% |
| 2013-12-31 | $13.45 B | -12.25% |
| 2012-12-31 | $15.33 B | 27.42% |
| 2011-12-31 | $12.03 B | 3.14% |
| 2010-12-31 | $11.66 B | -34.96% |
| 2009-12-31 | $17.93 B | -9.95% |
| 2008-12-31 | $19.91 B | -6.84% |
| 2007-12-31 | $21.37 B | 6.9% |
| 2006-12-31 | $19.99 B | 26% |
| 2005-12-31 | $15.87 B | 39.26% |
| 2004-12-31 | $11.39 B | -12.43% |
| 2003-12-31 | $13.01 B | -24.93% |
| 2002-12-31 | $17.33 B | -35.53% |
| 2001-12-31 | $26.89 B |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $22.92 B | 83.41% | 🇺🇸 USA |
 Novartis NVS | $13.96 B | 11.69% | 🇨🇭 Switzerland |
 Pfizer PFE | $12.69 B | 1.52% | 🇺🇸 USA |
 Abbott Laboratories ABT | $7.27 B | -41.77% | 🇺🇸 USA |
 Amgen AMGN | $10.94 B | -12.45% | 🇺🇸 USA |
 Sanofi SNY | $9.92 B | -20.58% | 🇫🇷 France |
 Becton Dickinson BDX | $1.18 B | -90.54% | 🇺🇸 USA |
 Merck MRK | $7.09 B | -43.26% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $6.35 B | -49.16% | 🇬🇧 UK |